Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer

Andrew Strickland; Peter Harper; Christos Karapetis; Christopher B. Steer; Desmond Yip

doi:10.1002/14651858.CD002889.pub2

Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer

Andrew Strickland^*, Peter Harper, Christos Karapetis, Christopher B. Steer, Desmond Yip

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to conduct a systematic review of the randomised trials comparing intravenous 5-fluorouracil with any oral fluoropyrimidine to assess the effect of chemotherapy on overall survival in patients with colo-rectal cancer. Our secondary objective will be to assess the relative response rates, toxicities and effects on quality of life of these two treatments.

Original language	English
Article number	CD002889
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	5
DOIs	https://doi.org/10.1002/14651858.CD002889.pub2
Publication status	Published - 20 May 2016
Externally published	Yes

Access to Document

10.1002/14651858.CD002889.pub2

Cite this

@article{e7534e25f0b84110a5576dd91258e2e6,

title = "Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to conduct a systematic review of the randomised trials comparing intravenous 5-fluorouracil with any oral fluoropyrimidine to assess the effect of chemotherapy on overall survival in patients with colo-rectal cancer. Our secondary objective will be to assess the relative response rates, toxicities and effects on quality of life of these two treatments.",

author = "Andrew Strickland and Peter Harper and Christos Karapetis and Steer, {Christopher B.} and Desmond Yip",

note = "Publisher Copyright: {\textcopyright} 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2016",

month = may,

day = "20",

doi = "10.1002/14651858.CD002889.pub2",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley & Sons Ltd.",

number = "5",

}

TY - JOUR

T1 - Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer

AU - Strickland, Andrew

AU - Harper, Peter

AU - Karapetis, Christos

AU - Steer, Christopher B.

AU - Yip, Desmond

PY - 2016/5/20

Y1 - 2016/5/20

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to conduct a systematic review of the randomised trials comparing intravenous 5-fluorouracil with any oral fluoropyrimidine to assess the effect of chemotherapy on overall survival in patients with colo-rectal cancer. Our secondary objective will be to assess the relative response rates, toxicities and effects on quality of life of these two treatments.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to conduct a systematic review of the randomised trials comparing intravenous 5-fluorouracil with any oral fluoropyrimidine to assess the effect of chemotherapy on overall survival in patients with colo-rectal cancer. Our secondary objective will be to assess the relative response rates, toxicities and effects on quality of life of these two treatments.

UR - http://www.scopus.com/inward/record.url?scp=84969529106&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD002889.pub2

DO - 10.1002/14651858.CD002889.pub2

M3 - Review article

SN - 1465-1858

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 5

M1 - CD002889

ER -

Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer

Abstract

Access to Document

Other files and links

Fingerprint

Cite this